BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20708344)

  • 1. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
    Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Interaction between Single Nucleotide Polymorphism of XRCC1, XRCC2, XRCC3 with Tumor Suppressor Tp53 Gene Increases Risk of Breast Cancer: A Hospital Based Case-Control Study.
    Datkhile KD; Gudur RA; Bhosale SJ; Durgawale PP; Jagdale NJ; More AL; Gudur AK; Patil SR
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3065-3075. PubMed ID: 37774058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The GSTM1null (deletion) and MGMT84 rs12917 (Phe/Phe) haplotype are associated with bulky DNA adduct levels in human leukocytes.
    Molina E; Pérez-Morales R; Rubio J; Petrosyan P; Cadena LH; Arlt VM; Phillips DH; Gonsebatt ME
    Mutat Res Genet Toxicol Environ Mutagen; 2013 Dec; 758(1-2):62-8. PubMed ID: 24084248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single Nucleotide Polymorphisms in DNA Repair Genes (XRCC1, XRCC2, XRCC3) and Their Association with Radiotherapy Toxicity among Head and Neck Cancer Patients:A Study from South-Western Maharashtra.
    Gudur AK; Gudur RA; Bhosale SJ; Kale SR; Datkhile KD
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3049-3057. PubMed ID: 37774056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Polymorphisms of XPC, XPD, XPG Genes and their Association with Radiotherapy Induced Toxicity among Head and Neck Cancer Patients: A Hospital Based Study from Maharashtra.
    Gudur AK; Kale SR; Gudur RA; Bhosale SJ; Datkhile KD
    Asian Pac J Cancer Prev; 2024 Jan; 25(1):191-199. PubMed ID: 38285784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer.
    Chang-Claude J; Ambrosone CB; Lilla C; Kropp S; Helmbold I; von Fournier D; Haase W; Sautter-Bihl ML; Wenz F; Schmezer P; Popanda O
    Br J Cancer; 2009 May; 100(10):1680-6. PubMed ID: 19367277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of DNA repair-related SNPs underlying susceptibility to papillary thyroid carcinoma reveals MGMT as a novel candidate gene in Belarusian children exposed to radiation.
    Lonjou C; Damiola F; Moissonnier M; Durand G; Malakhova I; Masyakin V; Le Calvez-Kelm F; Cardis E; Byrnes G; Kesminiene A; Lesueur F
    BMC Cancer; 2017 May; 17(1):328. PubMed ID: 28499365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients.
    Seibold P; Behrens S; Schmezer P; Helmbold I; Barnett G; Coles C; Yarnold J; Talbot CJ; Imai T; Azria D; Koch CA; Dunning AM; Burnet N; Bliss JM; Symonds RP; Rattay T; Suga T; Kerns SL; Bourgier C; Vallis KA; Sautter-Bihl ML; Claßen J; Debus J; Schnabel T; Rosenstein BS; Wenz F; West CM; Popanda O; Chang-Claude J
    Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1084-1092. PubMed ID: 26072091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA repair and cancer in colon and rectum: Novel players in genetic susceptibility.
    Pardini B; Corrado A; Paolicchi E; Cugliari G; Berndt SI; Bezieau S; Bien SA; Brenner H; Caan BJ; Campbell PT; Casey G; Chan AT; Chang-Claude J; Cotterchio M; Gala M; Gallinger SJ; Haile RW; Harrison TA; Hayes RB; Hoffmeister M; Hopper JL; Hsu L; Huyghe J; Jenkins MA; Le Marchand L; Lin Y; Lindor NM; Nan H; Newcomb PA; Ogino S; Potter JD; Schoen RE; Slattery ML; White E; Vodickova L; Vymetalkova V; Vodicka P; Gemignani F; Peters U; Naccarati A; Landi S
    Int J Cancer; 2020 Jan; 146(2):363-372. PubMed ID: 31209889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity.
    Dorling L; Barnett GC; Michailidou K; Coles CE; Burnet NG; Yarnold J; Elliott RM; Dunning AM; Pharoah PD; West CM
    Clin Cancer Res; 2016 Mar; 22(6):1413-20. PubMed ID: 26510858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single nucleotide polymorphisms of RecQ1, RAD54L, and ATM genes are associated with reduced survival of pancreatic cancer.
    Li D; Frazier M; Evans DB; Hess KR; Crane CH; Jiao L; Abbruzzese JL
    J Clin Oncol; 2006 Apr; 24(11):1720-8. PubMed ID: 16520463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations and patient-reported quality of life among patients with lung cancer.
    Sloan JA; de Andrade M; Decker P; Wampfler J; Oswold C; Clark M; Yang P
    J Clin Oncol; 2012 May; 30(14):1699-704. PubMed ID: 22454423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.
    Seibold P; Schmezer P; Behrens S; Michailidou K; Bolla MK; Wang Q; Flesch-Janys D; Nevanlinna H; Fagerholm R; Aittomäki K; Blomqvist C; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Lambrechts D; Wildiers H; Kristensen V; Alnæs GG; Nord S; Borresen-Dale AL; Hooning MJ; Hollestelle A; Jager A; Seynaeve C; Li J; Liu J; Humphreys K; Dunning AM; Rhenius V; Shah M; Kabisch M; Torres D; Ulmer HU; Hamann U; Schildkraut JM; Purrington KS; Couch FJ; Hall P; Pharoah P; Easton DF; Schmidt MK; Chang-Claude J; Popanda O
    BMC Cancer; 2015 Dec; 15():978. PubMed ID: 26674097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.
    Andreassen CN; Rosenstein BS; Kerns SL; Ostrer H; De Ruysscher D; Cesaretti JA; Barnett GC; Dunning AM; Dorling L; West CML; Burnet NG; Elliott R; Coles C; Hall E; Fachal L; Vega A; Gómez-Caamaño A; Talbot CJ; Symonds RP; De Ruyck K; Thierens H; Ost P; Chang-Claude J; Seibold P; Popanda O; Overgaard M; Dearnaley D; Sydes MR; Azria D; Koch CA; Parliament M; Blackshaw M; Sia M; Fuentes-Raspall MJ; Ramon Y Cajal T; Barnadas A; Vesprini D; Gutiérrez-Enríquez S; Mollà M; Díez O; Yarnold JR; Overgaard J; Bentzen SM; Alsner J;
    Radiother Oncol; 2016 Dec; 121(3):431-439. PubMed ID: 27443449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in DNA repair and oxidative stress pathways may modify the association between body size and postmenopausal breast cancer.
    McCullough LE; Eng SM; Bradshaw PT; Cleveland RJ; Steck SE; Terry MB; Shen J; Crew KD; Rossner P; Ahn J; Ambrosone CB; Teitelbaum SL; Neugut AI; Santella RM; Gammon MD
    Ann Epidemiol; 2015 Apr; 25(4):263-9. PubMed ID: 25703993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extreme acute radiation-induced toxicity in a patient with polymorphous low-grade adenocarcinoma of the nasopharynx and rare variants in DNA repair genes.
    Nowicka Z; Kuna K; Stawiski K; Sołek J; Świderek M; Papis-Ubych A; Fijuth J; Fendler W; Tomasik B
    Head Neck; 2024 Feb; 46(2):E10-E17. PubMed ID: 37867397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence Variants and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium.
    Chuang SC; Agudo A; Ahrens W; Anantharaman D; Benhamou S; Boccia S; Chen C; Conway DI; Fabianova E; Hayes RB; Healy CM; Holcatova I; Kjaerheim K; Lagiou P; Lazarus P; Macfarlane TV; Mahimkar MB; Mates D; Matsuo K; Merletti F; Metspalu A; Morgenstern H; Muscat J; Cadoni G; Olshan AF; Purdue M; Ramroth H; Rudnai P; Schwartz SM; Simonato L; Smith EM; Sturgis EM; Szeszenia-Dabrowska N; Talamini R; Thomson P; Wei Q; Zaridze D; Zhang ZF; Znaor A; Brennan P; Boffetta P; Hashibe M
    Front Oncol; 2011; 1():13. PubMed ID: 22655231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of DNA Repair and Oxidative Stress Genes Associated with Worst Pain in Breast Cancer Survivors on Aromatase Inhibitors.
    Wagner MA; Koleck TA; Conway A; Bender CM; Conley YP
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.
    Barnett GC; Kerns SL; Noble DJ; Dunning AM; West CM; Burnet NG
    Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):579-87. PubMed ID: 26166774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new approach for modeling patient overall radiosensitivity and predicting multiple toxicity endpoints for breast cancer patients.
    Mbah C; De Ruyck K; De Schrijver S; De Sutter C; Schiettecatte K; Monten C; Paelinck L; De Neve W; Thierens H; West C; Amorim G; Thas O; Veldeman L
    Acta Oncol; 2018 May; 57(5):604-612. PubMed ID: 29299946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.